These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 3649202
21. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci. Entenza JM, Vouillamoz J, Glauser MP, Moreillon P. Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523 [Abstract] [Full Text] [Related]
22. Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus. Kim YS, Liu Q, Chow LL, Chambers HF, Täuber MG. Antimicrob Agents Chemother; 1998 Dec; 42(12):3325-7. PubMed ID: 9835540 [Abstract] [Full Text] [Related]
23. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis. Kaatz GW, Seo SM, Reddy VN, Bailey EM, Rybak MJ. Antimicrob Agents Chemother; 1990 Nov; 34(11):2081-5. PubMed ID: 1963526 [Abstract] [Full Text] [Related]
24. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro. Chambers HF, Hackbarth CJ, Drake TA, Rusnak MG, Sande MA. J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133 [Abstract] [Full Text] [Related]
25. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus. Madrigal AG, Basuino L, Chambers HF. Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918 [Abstract] [Full Text] [Related]
26. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis. Perdikaris G, Giamarellou H, Pefanis A, Donta I, Karayiannakos P. Antimicrob Agents Chemother; 1995 Oct; 39(10):2289-94. PubMed ID: 8619584 [Abstract] [Full Text] [Related]
27. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination. Cantoni L, Glauser MP, Bille J. Antimicrob Agents Chemother; 1990 Dec; 34(12):2348-53. PubMed ID: 1965105 [Abstract] [Full Text] [Related]
29. Correlates of therapeutic efficacy in experimental methicillin-resistant Staphylococcus aureus endocarditis. Bayer AS, Greenberg DP, Yih J. Chemotherapy; 1988 Dec; 34(1):46-55. PubMed ID: 3162413 [Abstract] [Full Text] [Related]
30. Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus. Nicolau DP, Freeman CD, Nightingale CH, Coe CJ, Quintiliani R. Antimicrob Agents Chemother; 1994 Jul; 38(7):1515-8. PubMed ID: 7979281 [Abstract] [Full Text] [Related]
31. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus. Dailey CF, Dileto-Fang CL, Buchanan LV, Oramas-Shirey MP, Batts DH, Ford CW, Gibson JK. Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689 [Abstract] [Full Text] [Related]
32. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. Bayer AS, Lam K. J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588 [Abstract] [Full Text] [Related]
33. Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus. Chandrasekar PH, Levine DP, Price S, Rybak MJ. J Antimicrob Chemother; 1988 Apr; 21(4):461-9. PubMed ID: 3378959 [Abstract] [Full Text] [Related]
34. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. Faville RJ, Zaske DE, Kaplan EL, Crossley K, Sabath LD, Quie PG. JAMA; 1978 Oct 27; 240(18):1963-5. PubMed ID: 249793 [Abstract] [Full Text] [Related]
35. Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant. Voorn GP, Thompson J, Goessens WH, Schmal-Bauer WC, Broeders PH, Michel MF. J Antimicrob Chemother; 1994 Apr 27; 33(4):785-94. PubMed ID: 8056697 [Abstract] [Full Text] [Related]
36. Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis. Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ. Antimicrob Agents Chemother; 1989 Aug 27; 33(8):1184-7. PubMed ID: 2802547 [Abstract] [Full Text] [Related]
37. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Sorrell TC, Packham DR, Shanker S, Foldes M, Munro R. Ann Intern Med; 1982 Sep 27; 97(3):344-50. PubMed ID: 7114631 [Abstract] [Full Text] [Related]
38. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits. Chambers HF, Kartalija M, Sande M. J Infect Dis; 1995 Apr 27; 171(4):897-902. PubMed ID: 7706817 [Abstract] [Full Text] [Related]
39. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Levine DP, Cushing RD, Jui J, Brown WJ. Ann Intern Med; 1982 Sep 27; 97(3):330-8. PubMed ID: 7114630 [Abstract] [Full Text] [Related]
40. Comparison of fosfomycin and vancomycin therapy for experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. Rodríguez A, Vicente MV, Olay T. Eur J Clin Microbiol; 1985 Dec 27; 4(6):603-5. PubMed ID: 3853984 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]